Patients
23.7 % of people
People aged 65 and over, Germany, 2025 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Germany Orthobiologics Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$86.5 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $202.5 Mn | — | — |
| 2025 (base) | $210.4 Mn | +$7.9 Mn | — |
| 2026 (forecast) | $218.6 Mn | +$8.2 Mn | +3.9% |
| 2027 (forecast) | $227.1 Mn | +$8.5 Mn | +8% |
| 2028 (forecast) | $236.0 Mn | +$8.9 Mn | +12.2% |
| 2029 (forecast) | $245.2 Mn | +$9.2 Mn | +16.5% |
| 2030 (forecast) | $254.8 Mn | +$9.6 Mn | +21.1% |
| 2031 (forecast) | $264.7 Mn | +$9.9 Mn | +25.8% |
| 2032 (forecast) | $275.0 Mn | +$10.3 Mn | +30.7% |
| 2033 (forecast) | $285.7 Mn | +$10.7 Mn | +35.8% |
| 2034 (forecast) | $296.9 Mn | +$11.1 Mn | +41.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $210.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $296.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 3.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, application and end user (see all) |
| Key players | Medtronic, Stryker, Zimmer Biomet Holdings, Inc., Bioventus, Orthofix Medical (see all) |
| Regulator in Germany | BfArMSource: Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Orthobiologics use natural substances such as bone grafts, growth factors and cells to help bones and soft tissue heal.
Key segments of the orthobiologics market include product (Bone Grafts, Platelet-Rich Plasma and Stem Cells) and application (Spinal Fusion, Trauma and Sports Injuries).
An ageing and more active population, more sports injuries, rising obesity and better implants and procedures are driving the orthobiologics market.
Same-day joint surgery, robotics, smart implants and biologic treatments give the orthobiologics market room to grow.
High procedure costs, pricing pressure from hospitals, recalls and long recovery times hold back the orthobiologics market.
The orthobiologics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need CE marking under the EU Medical Device Regulation (MDR); in Germany, BfArM assesses reports of incidents with them.[1] Most people have statutory health insurance; the Federal Joint Committee (G-BA) decides what it covers and rates the added benefit of new medicines.[2] People aged 65 and over: 23.7% of people in 2025, the latest World Bank figure for Germany.[3]
[1] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.
[2] Federal Joint Committee (G-BA). Checked 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how orthobiologics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Germany.
What doctors and scientists are doing in Orthobiologics right now, from free public sources.
23.7 % of people
People aged 65 and over, Germany, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 16 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
From our blog
Germany · 1 shared keyword
Germany · 1 shared keyword
Germany · 1 shared keyword
Germany
Germany
Germany
Digital Health · Germany
Pharmaceuticals · Germany
Pharmaceuticals · Germany
OTC & Nutraceuticals · Germany
Healthcare Services · Germany
Pharmaceuticals · Germany